Syndrome News and Research

RSS

A gene regulatory multi-tool plays key role in unjamming the genome after DNA damage

A protein complex that is involved in nearly every step in the regulatory control of gene expression in cells has now been shown also to play a key role in clearing potential traffic jams in the production of RNA.

5 Apr 2019

Study uncovers genetic causes of poor sleep

The international collaboration, led by the University of Exeter and published in Nature Communications, has found 47 links between our genetic code and the quality, quantity and timing of how we sleep. They include ten new genetic links with sleep duration and 26 with sleep quality.

5 Apr 2019

Study: Consuming sugar does not improve mood and makes people more tired

Sugar does not improve mood and it can make people less alert and more tired after its consumption - according to a new study by the University of Warwick, Humboldt University of Berlin, and Lancaster University.

5 Apr 2019

Patent-pending probiotic could help patients with gastrointestinal diseases avoid harmful biofilms

Probiotics typically aim to rebalance bacteria populations in the gut, but new research suggests they may also help break apart stubborn biofilms. Biofilms are living microbial communities--they provide a haven for microbes and are often resistant to antibiotics.

4 Apr 2019

Study: Pathogenetic downregulation of adenosine linked to restless leg syndrome

Researchers have identified a common mechanism implicating adenosine in the cause of restless leg syndrome symptoms — the periodic limb movements characteristic of RLS and the state of enhanced arousal that both disrupt sleep.

4 Apr 2019

Compounds derived from common hop plant thwart cancer cells

The plant that adds flavor, color and bitterness to beer also produces a primary compound that thwarts cancer cells, and two important derivatives of the compound do as well, new research at Oregon State University shows.

3 Apr 2019

New mouse model for Joubert Syndrome developed

A new mouse model for Joubert Syndrome has been developed by University of Bath scientists, who hope it will accelerate research to understand how the disease develops as well as help develop and evaluate therapeutic approaches.

3 Apr 2019

Gout treatment could potentially reduce complications accompanying metabolic syndrome

The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health.

2 Apr 2019

Three easy-to-measure anthropometric indicators to predict metabolic syndrome

A new study found a surprisingly high rate of metabolic syndrome among individuals aged 60-100 years.

2 Apr 2019

People with treatment-resistant depression at higher risk of developing substance use syndrome

People suffering from treatment resistant depression are at a higher risk of developing substance use disorders than other patients with depression, reports a study by researchers at Karolinska Institutet in Sweden published in the journal Addiction.

2 Apr 2019

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Human immunodeficiency virus, or HIV, attacks the immune system, making affected individuals more susceptible to infections. When patients with HIV are treated with antiretroviral therapy, their immune system can recover, but some of them produce self-destructive proteins, or autoantibodies.

2 Apr 2019

Potential target for Group A Streptococcus vaccine identified

Most people think of "strep throat" as a relatively benign infection cured by a round of antibiotics and a few days of rest. But the bacterium that causes strep throat -- Group A Streptococcus -- is also responsible for a number of much more dangerous disorders, including rheumatic heart disease and toxic shock syndrome.

1 Apr 2019

Colorecal cancer commonly misdiagnosed in patients under 50

A recent survey has found that a significant number of patients who develop colorectal cancer (CRC) before the age of 50 are misdiagnosed several times.

1 Apr 2019

Research reveals genomic basis of acute erythroid leukemia

Acute erythroid leukemia is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital that appears today in the journal Nature Genetics.

30 Mar 2019

Gastrointestinal symptoms in children could be a red flag for future mental health problems

A Columbia University study has found that adversity early in life is associated with increased gastrointestinal symptoms in children that may have an impact on the brain and behavior as they grow to maturity.

29 Mar 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

29 Mar 2019

Fetal exposure to nicotine linked with SIDS and cardiac arrhythmias in newborns

Fetal exposure to tobacco smoke in utero is associated with sudden infant death syndrome (SIDS) and cardiac arrhythmias in newborns. In a novel study in rabbits, investigators provide the first evidence linking fetal exposure to nicotine to long-term alterations of the cardiac sodium current.

29 Mar 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

FDA approves new oral treatment for men with certain forms of hypogonadism

The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism.

27 Mar 2019

Syndrome News and Research

A gene regulatory multi-tool plays key role in unjamming the genome after DNA damage

Study uncovers genetic causes of poor sleep

Study: Consuming sugar does not improve mood and makes people more tired

Patent-pending probiotic could help patients with gastrointestinal diseases avoid harmful biofilms

Study: Pathogenetic downregulation of adenosine linked to restless leg syndrome

Compounds derived from common hop plant thwart cancer cells

New mouse model for Joubert Syndrome developed

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Three easy-to-measure anthropometric indicators to predict metabolic syndrome

People with treatment-resistant depression at higher risk of developing substance use syndrome

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Potential target for Group A Streptococcus vaccine identified

Colorecal cancer commonly misdiagnosed in patients under 50

Research reveals genomic basis of acute erythroid leukemia

Gastrointestinal symptoms in children could be a red flag for future mental health problems

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

Fetal exposure to nicotine linked with SIDS and cardiac arrhythmias in newborns

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

FDA approves new oral treatment for men with certain forms of hypogonadism

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News